Search Results - jennifer+van+eyk

5 Results

Sort By:

C12557: CARDIAC INJURY DIAGNOSTIC BIOMARKERSInvention novelty: Biomarkers identified for accurate and differential diagnosis and prognosis of cardiac injury and associated delayed adverse event related risksValue Proposition: Currently, various tests have been used to detect myocardial events. The clinically available tests include assays for measuring...

Published: 3/13/2025 | Inventor(s): Qin Fu, Jennifer Van Eyk, Vidya Venkatraman

Keywords(s): Biomarker, Cardiovascular Diseases, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Myocardial Infarction, Myocardial Infarction (MI)

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Cardiovascular > Myocardial Infarction, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Clinical and Disease Specializations > Cardiovascular, Technology Classifications > Diagnostics

Alteration of the Albumin-bound Protein/peptide Complex (ABPPC) is Biomarker for Disease

Alteration of the Albumin-bound Protein/peptide Complex (ABPPC) is Biomarker for DiseaseC04997Backgrounds JHU scientists have invented a cost-effective, rapid, and sensitive assay that characterizes proteins differentially bound to albumin in diseased and healthy patients and is compatible with current blood collection protocols. The current hypothesis...

Published: 3/13/2025 | Inventor(s): Robert Cotter, Rebekah Gundry, Jennifer Van Eyk

Keywords(s): Biomarker, Clinical Diagnostics, Diagnostic Biomarker, In Vitro Diagnostics

Category(s): Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics

MRM Assay Measurement of Amyloid Precursor Protein in Healthy and Alzheimers Disease Cerebrospinal Fluids

C12148: Method for Measuring Amyloid Precursor Proteins for Alzheimer’s DiseaseNovelty: This invention develops a method to measure the concentrations of various forms of Amyloid Precursor Proteins (APP) in cerebrospinal fluid (CSF).Value Proposition: Alzheimer's disease (AD) is the most common form of dementia. There is no cure for the disease....

Published: 3/13/2025 | Inventor(s): Jennifer Van Eyk, Xiaoqian Liu, Richard O'brien

Keywords(s): Alzheimer's Disease, Assay, Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Disease Indication, In Vitro Diagnostics, Mechanism-of-action Biomarker, Neurodegeneration, Therapeutic Matter, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Geriatrics, Clinical and Disease Specializations > Neurology > Alzheimer's Disease, Clinical and Disease Specializations > Neurology > Neurodegeneration, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Research Tools > Assays, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Neurology, Technology Classifications > Research Tools, Technology Classifications > Therapeutic Modalities

Biomarkers of Myocardial Ischemia

C10179: Biomarkers of Myocardial IschemiaValue Proposition: Detection of ischemic myocardium as an early indication of cardiac injury allowing early detection of myocardial infarction and cell death.Technical Details: Coronary heart disease is the most common single cause of death in the western world representing ~20% of all deaths. This is equivalent...

Published: 3/13/2025 | Inventor(s): Qin Fu, Simon Sheng, Jennifer Van Eyk

Keywords(s): Biomarker, Cardiovascular Diseases, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Myocardial Infarction, Myocardial Infarction (MI)

Development of Peptide Antibody Depletion (PAD) and its Application to Mass Spectrometry Sample Preparation

C04975: Development of Peptide Antibody Depletion (PAD) and its Application to Mass Spectrometry Sample Preparation Technical Details: One of the major limitations of mass spectrometry is obtaining mass information on proteins in the presence of contaminating materials or other high abundant proteins that, when present in the sample, suppress the...

Published: 3/13/2025 | Inventor(s): David Graham, Rebekah Gundry, Jennifer Van Eyk

Keywords(s): Basic Research Biomarker, Discovery/Research Tools, In Vitro Research Tool, Research Instrument

Category(s): Technology Classifications > Research Tools